Last $189.53 USD
Change Today +0.57 / 0.30%
Volume 2.1M
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas A. Bock M.D., M.B.A.

Former Senior Vice President of Global Medical Affairs, Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

----

Background*

Dr. Thomas A. Bock,,M.D. M.B.A. served as Senior Vice President of Global Medical Affairs at Alexion Pharmaceuticals, Inc. since 2010. In this position, Mr. Bock led Alexion's medical research collaborations and scientific communications as well as Alexion's medical country operations worldwide. Dr. Bock has a broad range of scientific and international business experience to Alexion, having built successful entrepreneurial, cross-functional organizations in pharmaceutical ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
INSEAD
Unknown/Other Education
Harvard University
MD
Rheinisch-Westfälische Technische Hochschule Aachen
Unknown/Other Education
Columbia University
MBA
Columbia University
Unknown/Other Education
Shanghai University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $189.53 USD +0.57

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Stephen Edward Foots Chief Executive Officer, Executive Director, Chairman of Group Executive Committee, Member of Risk Management Committee, Member of Routine Business Committee, Member of Nomination Committee, Member of Finance Committee and Member of Group Safety, Health & Environment Steering Committee
Croda International plc
535.0K GBP
Heinz-Jürgen Bertram Ph.D.Chairman of Executive Board, Chief Executive Officer and Labour Director
Symrise AG
€1.1M
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Chief Executive Officer, Member of The Management Council, Director, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee
Dr. Reddy's Laboratories Ltd.
6.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.